Serratia Endocarditis
- 1 February 1980
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 140 (2) , 199-202
- https://doi.org/10.1001/archinte.1980.00330140057018
Abstract
• Seventeen new cases ofSerratia marcescensendocarditis observed in the San Francisco Bay Area since June 1974 are presented. Fifteen patients had a history of illicit intravenous drug use and four patients had prosthetic heart valves. Seven patients with infection of right-sided heart valves did well, although surgery was required in two for persistent fever or recurrent pulmonary emboli. Only three of ten patients with left-sided infection survived despite synergistic antibiotic combinations and high serum bactericidal titers. Fifteen isolates ofSerratiafrom patients with endocarditis were serotyped, and none of these serotypes corresponded to the pigmented strain aerosolized by the US Army in the Bay Area in 1951. The isolation of the sameSerratiastrain from two patients and their shared injection paraphernalia provided insight into the pathogenesis of endocarditis in the intravenous drug user. A revised therapeutic approach to this difficult infection is presented. (Arch Intern Med140:199-202, 1980)This publication has 5 references indexed in Scilit:
- Netilmicin synergy with carbenicillin or cefamandole against Serratia.The Journal of Antibiotics, 1978
- In Vitro Activity of Gentamicin, Amikacin, and Netilmicin Alone and in Combination with Carbenicillin Against Serratia marcescensAntimicrobial Agents and Chemotherapy, 1976
- Serratia marcescens infections—selection of an antibioticJournal of Antimicrobial Chemotherapy, 1976
- Regional Pathogens in Endocarditis?Annals of Internal Medicine, 1976
- Sulfamethoxazole-Trimethoprim-Polymyxin Therapy of Serious Multiply Drug-Resistant Serratia InfectionsAntimicrobial Agents and Chemotherapy, 1976